Kunin M et al. |
Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review. |
2014 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:24569948
|
Fan Y et al. |
High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis. |
2014 |
J Laryngol Otol |
pmid:24555753
|
Liu KS et al. |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. |
2014 |
Gut |
pmid:24295850
|
Hanson KE et al. |
Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing? |
2014 |
J. Clin. Microbiol. |
pmid:24554745
|
Miwa S et al. |
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. |
2014 |
Ann Am Thorac Soc |
pmid:24298907
|
Almeida N et al. |
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study. |
2014 |
Helicobacter |
pmid:24506175
|
Tan X and Song Z |
Human saliva-based quantitative monitoring of clarithromycin by flow injection chemiluminescence analysis: a pharmacokinetic study. |
2014 |
Appl. Biochem. Biotechnol. |
pmid:24166104
|
Kakuda TN et al. |
Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies. |
2014 |
J. Antimicrob. Chemother. |
pmid:24155058
|
Seung KJ et al. |
Salvage therapy for multidrug-resistant tuberculosis. |
2014 |
Clin. Microbiol. Infect. |
pmid:23991934
|
Yakoob J et al. |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. |
2014 |
Microb. Drug Resist. |
pmid:23844851
|
Markert C et al. |
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers. |
2014 |
Br J Clin Pharmacol |
pmid:23738582
|
Kathariya R et al. |
Evaluation of subgingivally delivered 0.5% clarithromycin as an adjunct to nonsurgical mechanotherapy in the management of chronic periodontitis: a short-term double blinded randomized control trial. |
2014 |
J Investig Clin Dent |
pmid:23097216
|
Maev IV et al. |
[Eradication therapy for Helicobacter pylori infection: review of world trends]. |
2014 |
Ter. Arkh. |
pmid:24779078
|
Katagiri S et al. |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia]. |
2014 |
Nippon Naika Gakkai Zasshi |
pmid:24796145
|
Kato M |
[Expanded indication of National Health Insurance for H. pylori associated gastritis]. |
2014 |
Nippon Rinsho |
pmid:24912302
|
Bjerre M et al. |
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. |
2014 |
Scand. J. Clin. Lab. Invest. |
pmid:25026506
|
Khoshnood A et al. |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial. |
2014 |
J Med Life |
pmid:25408735
|
Noh TK et al. |
Infection with Mycobacterium fortuitum during acupoint embedding therapy. |
2014 |
J. Am. Acad. Dermatol. |
pmid:24831334
|
Fowler J and Mahlen SD |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria. |
2014 |
Arch. Pathol. Lab. Med. |
pmid:25076301
|
Ueda Y et al. |
[Obstructive pneumonia and brain abscess due to Nocardia elegans in a patient with systemic lupus erythematosus]. |
2014 |
Kansenshogaku Zasshi |
pmid:24974451
|
NegrÃn-González J et al. |
Psychiatric adverse reaction induced by clarithromycin. |
2014 |
Eur Ann Allergy Clin Immunol |
pmid:24853570
|
Kurosaki Y et al. |
[Two cases of pulmonary Mycobacterium avium complex disease with resistance to clarithromycin]. |
2014 |
Kekkaku |
pmid:24979948
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Tümgör G et al. |
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children. |
2014 |
Turk J Gastroenterol |
pmid:25910378
|
Çiftci İH et al. |
Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori. |
2014 |
Turk J Gastroenterol |
pmid:25910373
|
Altman E et al. |
Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori. |
2014 |
Can. J. Microbiol. |
pmid:24392924
|
Kim SY et al. |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease. |
2014 |
Clin. Exp. Immunol. |
pmid:24354934
|
De Francesco V et al. |
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. |
2014 |
J. Med. Microbiol. |
pmid:24344205
|
Yamada K et al. |
Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells. |
2014 |
Pulm Pharmacol Ther |
pmid:24910464
|
Lee JY et al. |
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. |
2014 |
Dig. Dis. Sci. |
pmid:24599773
|
Zhao HM et al. |
[Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children]. |
2014 |
Zhongguo Dang Dai Er Ke Za Zhi |
pmid:24661511
|
Ohe M and Hashino S |
Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin. |
2014 |
J. Formos. Med. Assoc. |
pmid:24630039
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Heo J and Jeon SW |
[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651586
|
Kang BK et al. |
[New therapeutic strategies against Helicobacter pylori]. |
2014 |
Korean J Gastroenterol |
pmid:24651587
|
Patsche CB et al. |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement. |
2014 |
Int. J. Infect. Dis. |
pmid:25008771
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Koh S et al. |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis. |
2014 |
J AAPOS |
pmid:24568999
|
Ke AB et al. |
Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies. |
2014 |
Clin. Pharmacol. Ther. |
pmid:24747234
|
Ghosh N et al. |
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma. |
2014 |
Am. J. Hematol. |
pmid:24723438
|
Mendu ML and Waikar SS |
Drug-drug interactions and acute kidney injury: caveat prescriptor. |
2014 |
Am. J. Kidney Dis. |
pmid:24820318
|
Gisbert JP et al. |
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection. |
2014 |
Dig. Dis. Sci. |
pmid:24126798
|
Kuroda H et al. |
[Three cases of lenalidomide-resistant IgA myeloma for which a response was regained after the addition of clarithromycin]. |
2014 |
Gan To Kagaku Ryoho |
pmid:25248908
|
Farley R et al. |
Antibiotics for bronchiolitis in children under two years of age. |
2014 |
Cochrane Database Syst Rev |
pmid:25300167
|
Methaneethorn J et al. |
A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans. |
2014 |
Conf Proc IEEE Eng Med Biol Soc |
pmid:25571290
|
Hajaghamohammadi A et al. |
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial. |
2014 |
Glob J Health Sci |
pmid:25560342
|
Iwanczak B et al. |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554984
|
Rakici H et al. |
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. |
2014 |
Digestion |
pmid:25547786
|
Karamanolis GP et al. |
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece. |
2014 |
Digestion |
pmid:25531953
|
Hemphill A et al. |
Treatment of echinococcosis: albendazole and mebendazole--what else? |
2014 |
Parasite |
pmid:25526545
|
Kawai T et al. |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). |
2014 |
J. Gastroenterol. Hepatol. |
pmid:25521730
|
Kim SY et al. |
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication]. |
2014 |
Korean J Gastroenterol |
pmid:25420735
|
Mustafa G and Necati B |
Clarithromycin-associated rhabdomyolysis in an infant. |
2014 |
J Clin Rheumatol |
pmid:25417692
|
Hashim H et al. |
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. |
2014 |
PLoS ONE |
pmid:25411976
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Yangco BG et al. |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? |
2014 |
AIDS Patient Care STDS |
pmid:24833016
|
Martos M et al. |
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions. |
2014 |
Eur J Gastroenterol Hepatol |
pmid:25229983
|
Veraldi S et al. |
Treatment of sporotrichoid fish tank granuloma with pulsed clarithromycin. |
2014 |
Dermatology (Basel) |
pmid:25228273
|
Phillips RO et al. |
Reply to "compliance with antimicrobial therapy for buruli ulcer". |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225343
|
Klis S et al. |
Compliance with antimicrobial therapy for buruli ulcer. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225342
|
Mitui M et al. |
Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance. |
2014 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:25222804
|
Gold BD |
Resistance testing for Helicobacter pylori infection: is it finally ready for prime time? |
2014 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:25222802
|
Morakul B et al. |
Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method. |
2014 |
Eur J Pharm Biopharm |
pmid:25201298
|
Parekh TM et al. |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. |
2014 |
JAMA Intern Med |
pmid:25179404
|
Kutluk G et al. |
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains? |
2014 |
Eur J Gastroenterol Hepatol |
pmid:25171023
|
Higashi F et al. |
Additional treatment with clarithromycin reduces fever duration in patients with influenza. |
2014 |
Respir Investig |
pmid:25169846
|
de Boer EM et al. |
[Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment]. |
2014 |
Ned Tijdschr Geneeskd |
pmid:25159698
|
Elkhatib W and Noreddin A |
Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model. |
2014 |
Microb. Drug Resist. |
pmid:25050970
|
Ohe M and Bohgaki T |
Successful treatment with clarithromycin for patients with polymyalgia rheumatica. |
2014 |
Korean J. Intern. Med. |
pmid:25045305
|
Martin JH and Coombes I |
Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing. |
2014 |
Intern Med J |
pmid:25041768
|
Bansal S and Chhibber S |
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice. |
2014 |
J Infect Dev Ctries |
pmid:25022293
|
Fouka E et al. |
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients. |
2014 |
Lung |
pmid:25016929
|
Lambert D et al. |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients. |
2014 |
Med Mal Infect |
pmid:25015308
|
Dalbøge CS et al. |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. |
2014 |
J. Cyst. Fibros. |
pmid:24035278
|
Teh X et al. |
Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur. |
2014 |
PLoS ONE |
pmid:25003707
|
Lyons J et al. |
An unusual lung mass post stem cell transplantation. |
2014 |
Transpl Infect Dis |
pmid:24995624
|
Lee JW et al. |
A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24988873
|
Glatz M and Muellegger RR |
Drug-associated aquagenic wrinkling of the palms in an atopic male patient. |
2014 |
BMJ Case Rep |
pmid:24903725
|
DiCicco M et al. |
In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius. |
2014 |
BMC Microbiol. |
pmid:24886369
|
Noonan KA et al. |
Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma. |
2014 |
Cancer Immunol Res |
pmid:24878583
|
Gong EJ et al. |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? |
2014 |
J. Korean Med. Sci. |
pmid:24851029
|
Jeon HK and Kim GH |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea? |
2014 |
J. Korean Med. Sci. |
pmid:24851014
|
Rasheed F et al. |
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. |
2014 |
Helicobacter |
pmid:24827414
|
Wang Y et al. |
Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. |
2014 |
Helicobacter |
pmid:24826809
|
Graham DY et al. |
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. |
2014 |
Clin. Gastroenterol. Hepatol. |
pmid:23751282
|
Pan-In P et al. |
Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. |
2014 |
Carbohydr Polym |
pmid:24815396
|
Ichihara A et al. |
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis. |
2014 |
J. Dermatol. |
pmid:24801916
|
Togami K et al. |
Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin. |
2014 |
Biopharm Drug Dispos |
pmid:24801141
|
Bernut A et al. |
In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798271
|
Adebisi AO and Conway BR |
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus. |
2014 |
Int J Pharm |
pmid:24792977
|
Binh TT et al. |
Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. |
2014 |
J. Antimicrob. Chemother. |
pmid:24648504
|
Tursi A et al. |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study. |
2014 |
Panminerva Med |
pmid:24637473
|
Wei Z et al. |
Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients. |
2014 |
Helicobacter |
pmid:24617669
|
Wu JY et al. |
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. |
2014 |
Helicobacter |
pmid:24612093
|
Settin A et al. |
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. |
2014 |
Indian J Gastroenterol |
pmid:24610583
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|
Okame M et al. |
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy. |
2014 |
Clin. Infect. Dis. |
pmid:24585569
|
Mark TM et al. |
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. |
2014 |
Leuk. Lymphoma |
pmid:24576165
|
Zhang J et al. |
Ocular penetration and pharmacokinetics of topical clarithromycin eye drops to rabbits. |
2014 |
J Ocul Pharmacol Ther |
pmid:24199739
|
Takazono T et al. |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. |
2014 |
BMC Infect. Dis. |
pmid:24576098
|